Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Holland, Ashling ^a   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

CARDIOMYOPATHY; DISEASE ASSOCIATION; DYSTROPHINOPATHY; DYSTROPHINOPATHY ASSOCIATED CARDIOMYOPATHY; HUMAN; MASS SPECTROMETRY; NONHUMAN; PATHOGENESIS; PROTEOMICS; REVIEW; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; CARDIOMYOPATHIES; COMPLICATION; DEFICIENCY; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION PROFILING; GENETICS; MOUSE; PATHOLOGY; PHENOTYPE; PROTEIN SYNTHESIS;

ANIMALS; CARDIOMYOPATHIES; DYSTROPHIN; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; PHENOTYPE; PROTEIN BIOSYNTHESIS; PROTEOMICS;

EID: 84897480885     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/246195     Document Type: Review

References (193)

1. Hoffman E. P., Brown R. H. Jr., Kunkel L. M., Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987 51 6 919 928 2-s2.0-0023614188
2. Koening M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M., Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987 50 3 509 517 2-s2.0-0023614271 (Pubitemid 18098338)
3. Koening M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Muller C. R., Lindlof M., Kaariainen H., de la Chapelle A., Kiuru A., Savontaus M., Gilgenkrantz H., Recan D., Chelly J., Kaplan J., Covone A. E., Archidiacono N., The molecular basis for Duchenne versus becker muscular dystrophy: correlation of severity with type of deletion. The American Journal of Human Genetics 1989 45 4 498 506 2-s2.0-0024466501 (Pubitemid 19261437)
4. Towbin J. A., Hejtmancik J. F., Brink P., Gelb B., Zhu X. M., Chamberlain J. S., McCabe E. R. B., Swift M., X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993 87 6 1854 1865 2-s2.0-0027193330 (Pubitemid 23165627)
5. Ortiz-Lopez R., Li H., Su J., Goytia V., Towbin J. A., Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation 1997 95 10 2434 2440 2-s2.0-0030922569 (Pubitemid 27224739)
6. Diegoli M., Grasso M., Favalli V., Serio A., Gambarin F. I., Klersy C., Pasotti M., Agozzino E., Scelsi L., Ferlini A., Febo O., Piccolo G., Tavazzi L., Narula J., Arbustini E., Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. Journal of the American College of Cardiology 2011 58 9 925 934 2-s2.0-84860390502 10.1016/j.jacc.2011. 01.072
7. Helbling-Leclerc A., Zhang X., Topaloglu H., Cruaud C., Tesson F., Weissenbach J., Tome F. M. S., Schwartz K., Fardeau M., Tryggvason K., Guicheney P., Mutations in the laminin α 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genetics 1995 11 2 216 218 2-s2.0-0028980027
8. Nigro V., de Sa Moreira E., Piluso G., Vainzof M., Belsito A., Politano L., Puca A. A., Passos-Bueno M. R., Zatz M., Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ -sarcoglycan gene. Nature Genetics 1996 14 2 195 198 2-s2.0-0029816797 10.1038/ng1096-195 (Pubitemid 26338803)
9. Godfrey C., Clement E., Mein R., Brockington M., Smith J., Talim B., Straub V., Robb S., Quinlivan R., Feng L., Jimenez-Mallebrera C., Mercuri E., Manzur A. Y., Kinali M., Torelli S., Brown S. C., Sewry C. A., Bushby K., Topaloglu H., North K., Abbs S., Muntoni F., Refining genotype-phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007 130 10 2725 2735 2-s2.0-34848837334 10.1093/brain/awm212 (Pubitemid 47511718)
10. Emery A. E. H., The muscular dystrophies. The Lancet 2002 359 9307 687 695 2-s2.0-0037160782 10.1016/S0140-6736(02)07815-7 (Pubitemid 34203773)
11. Hauser E., Toifl K., Mad A., Bittner R., The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening. Wiener Klinische Wochenschrift 1993 105 15 433 436 2-s2.0-0027346478
12. Mendell J. R., Lloyd-Puryear M., Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy. Muscle and Nerve 2013 48 1 21 26 10.1002/mus.23810
13. Moat S. J., Bradley D. M., Salmon R., Clarke A., Hartley L., Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). European Journal of Human Genetics 2013 21 10 1049 1053 10.1038/ejhg.2012.301
14. Zatz M., Rapaport D., Vainzof M., Passos-Bueno M. R., Bortolini E. R., de Cassia Pavanello M. R., Peres C. A., Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. Journal of the Neurological Sciences 1991 102 2 190 196 2-s2.0-0025801496 10.1016/0022-510X(91)90068-I
15. Ohta M., Itagaki Y., Itoh N., Hayashi K., Nishitani H., Ohta K., Carbonic anhydrase III in serum in muscular dystrophy and other neurological disorders: relationship with creatine kinase. Clinical Chemistry 1991 37 1 36 39 2-s2.0-0026034017 (Pubitemid 21892598)
16. Mendell J. R., Shilling C., Leslie N. D., Flanigan K. M., Al-Dahhak R., Gastier-Foster J., Kneile K., Dunn D. M., Duval B., Aoyagi A., Hamil C., Mahmoud M., Roush K., Bird L., Rankin C., Lilly H., Street N., Chandrasekar R., Weiss R. B., Evidence-based path to newborn screening for duchenne muscular dystrophy. Annals of Neurology 2012 71 3 304 313 2-s2.0-84859181514 10.1002/ana.23528
17. Carberry S., Ohlendieck K., Gel electrophoresis-based proteomics of senescent tissues. Biological Aging 2013 1048 229 246 Methods in Molecular Biology 10.1007/978-1-62703-556-9-17
18. Holland A., Dowling P., Zweyer M., Swandulla D., Henry M., Clynes M., Ohlendieck K., Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin. Proteomics 2013 13 15 2312 2323 10.1002/pmic.201200578
19. Franceschini A., Szklarczyk D., Frankild S., Kuhn M., Simonovic M., Roth A., Lin J., Minguez P., Bork P., von Mering C., Jensen L. J., STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Research 2013 41 D808 D815 10.1093/nar/gks1094
20. Bushby K., Finkel R., Birnkrant D. J., Case L. E., Clemens P. R., Cripe L., Kaul A., Kinnett K., McDonald C., Pandya S., Poysky J., Shapiro F., Tomezsko J., Constantin C., Diagnosis and management of Duchenne muscular dystrophy-part 1: diagnosis, and pharmacological and psychosocial management. The Lancet Neurology 2010 9 1 77 93 2-s2.0-72149108443 10.1016/S1474-4422(09)70271-6
21. Bushby K., Finkel R., Birnkrant D. J., Case L. E., Clemens P. R., Cripe L., Kaul A., Kinnett K., McDonald C., Pandya S., Poysky J., Shapiro F., Tomezsko J., Constantin C., Diagnosis and management of Duchenne muscular dystrophy-part 2: implementation of multidisciplinary care. The Lancet Neurology 2010 9 2 177 189 2-s2.0-76549130473 10.1016/S1474-4422(09)70272-8
22. Hoffman E. P., Fischbeck K. H., Brown R. H., Johnson M., Medori R., Loike J. D., Harris J. B., Waterston R., Brooke M., Specht L., Kupsky W., Chamberlain J., Caskey C. T., Shapiro F., Kunkel L. M., Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. The New England Journal of Medicine 1988 318 21 1363 1368 2-s2.0-0023906647
23. Thanh L. T., Man N. T., Helliwell T. R., Morris G. E., Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. The American Journal of Human Genetics 1995 56 3 725 731 2-s2.0-0028910144
24. Kozicka A., Prot J., Wasilewski R., Mental retardation in patients with Duchenne progressive muscular dystrophy. Journal of the Neurological Sciences 1971 14 2 209 213 2-s2.0-0015142051
25. Pane M., Lombardo M. E., Alfieri P., D'Amico A., Bianco F., Vasco G., Piccini G., Mallardi M., Romeo D. M., Ricotti V., Ferlini A., Gualandi F., Vicari S., Bertini E., Berardinelli A., Mercuri E., Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. Journal of Pediatrics 2012 161 4 705 709 2-s2.0-84860551933 10.1016/j.jpeds.2012.03.020
26. Kinali M., Messina S., Mercuri E., Lehovsky J., Edge G., Manzur A. Y., Muntoni F., Management of scoliosis in Duchenne muscular dystrophy: a large 10-year retrospective study. Developmental Medicine and Child Neurology 2006 48 6 513 518 2-s2.0-33646700713 10.1017/S0012162206001083 (Pubitemid 43740916)
27. Hsu J. D., Quinlivan R., Scoliosis in Duchenne muscular dystrophy (DMD). Neuromuscular Disorders 2013 23 8 611 617 10.1016/j.nmd.2013.05.003
28. Gayraud J., Ramonatxo M., Rivier F., Humberclaude V., Petrof B., Matecki S., Ventilatory parameters and maximal respiratory pressure changes with age in duchenne muscular dystrophy patients. Pediatric Pulmonology 2010 45 6 552 559 2-s2.0-77953305476 10.1002/ppul.21204
29. Khirani S., Ramirez A., Aubertin G., Respiratory muscle decline in duchenne muscular dystrophy. Pediatric Pulmonology 2013 10.1002/ppul.22847
30. Connuck D. M., Sleeper L. A., Colan S. D., Cox G. F., Towbin J. A., Lowe A. M., Wilkinson J. D., Orav E. J., Cuniberti L., Salbert B. A., Lipshultz S. E., Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the pediatric cardiomyopathy registry. The American Heart Journal 2008 155 6 998 1005 2-s2.0-44349129859 10.1016/j.ahj.2008.01.018
31. Romfh A., McNally E. M., Cardiac assessment in duchenne and becker muscular dystrophies. Current Heart Failure Reports 2010 7 4 212 218 2-s2.0-78649668751 10.1007/s11897-010-0028-2
32. Bach J. R., Martinez D., Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respiratory Care 2011 56 6 744 750 2-s2.0-79960665553 10.4187/respcare.00831
33. Ishikawa Y., Miura T., Ishikawa Y., Aoyagi T., Ogata H., Hamada S., Minami R., Duchenne muscular dystrophy: survival by cardio-respiratory interventions. Neuromuscular Disorders 2011 21 1 47 51 2-s2.0-78650418478 10.1016/j.nmd.2010.09.006
34. Passamano L., Taglia A., Palladino A., Viggiano E., D'Ambrosio P., Scutifero M., Cecio M. R., Torre V., de Luca F., Picillo E., Paciello O., Piluso G., Nigro G., Politano L., Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients. Acta Myologica 2012 31 2 121 125
35. Koenig M., Kunkel L. M., Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. The Journal of Biological Chemistry 1990 265 8 4560 4566 2-s2.0-0025217703
36. Campbell K. P., Kahl S. D., Association of dystrophin and an integral membrane glycoprotein. Nature 1989 338 6212 259 262 2-s2.0-0024600620 (Pubitemid 19086928)
37. Yoshida M., Ozawa E., Glycoprotein complex anchoring dystrophin to sarcolemma. Journal of Biochemistry 1990 108 5 748 752 2-s2.0-0025242185
38. Ervasti J. M., Ohlendieck K., Kahl S. D., Gaver M. G., Campbell K. P., Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990 345 6273 315 319 2-s2.0-0025272250 10.1038/345315a0 (Pubitemid 20159538)
39. Ervasti J. M., Campbell K. P., A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. Journal of Cell Biology 1993 122 4 809 823 2-s2.0-0027275643 (Pubitemid 23241091)
40. Ohlendieck K., Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. European Journal of Cell Biology 1996 69 1 1 10 2-s2.0-0030026119 (Pubitemid 26033923)
41. Gee S. H., Madhavan R., Levinson S. R., Caldwell J. H., Sealock R., Froehner S. C., Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. Journal of Neuroscience 1998 18 1 128 137 2-s2.0-0031974345 (Pubitemid 28046774)
42. Yoshida M., Noguchi S., Wakabayashi E., Piluso G., Belsito A., Nigro V., Ozawa E., The fourth component of the sarcoglycan complex. FEBS Letters 1997 403 2 143 148 2-s2.0-0031056965 10.1016/S0014-5793(97)00040-9 (Pubitemid 27081483)
43. Peters M. F., O'Brien K. F., Sadoulet-Puccio H. M., Kunkel L. M., Adams M. E., Froehner S. C., β -dystrobrevin, a new member of the dystrophin family: identification, cloning, and protein associations. The Journal of Biological Chemistry 1997 272 50 31561 31569 2-s2.0-0031467311 10.1074/jbc.272.50.31561 (Pubitemid 28013298)
44. Crosbie R. H., Heighway J., Venzke D. P., Lee J. C., Campbell K. P., Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. The Journal of Biological Chemistry 1997 272 50 31221 31224 2-s2.0-0031451562 10.1074/jbc.272.50.31221 (Pubitemid 28013250)
45. Ohlendieck K., Ervasti J. M., Snook J. B., Campbell K. P., Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. Journal of Cell Biology 1991 112 1 135 148 2-s2.0-0026067790 10.1083/jcb.112.1.135 (Pubitemid 21909606)
46. Ohlendieck K., Ervasti J. M., Matsumura K., Kahl S. D., Leveille C. J., Campbell K. P., Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 1991 7 3 499 508 2-s2.0-0026094250 10.1016/0896-6273(91)90301-F
47. Matsumura K., Ervasti J. M., Ohlendieck K., Kahl S. D., Campbell K. P., Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992 360 6404 588 591 2-s2.0-0026621608 10.1038/360588a0 (Pubitemid 23000708)
48. Klietsch R., Ervasti J. M., Arnold W., Campbell K. P., Jorgensen A. O., Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle. Circulation Research 1993 72 2 349 360 2-s2.0-0027533969 (Pubitemid 23024523)
49. Kaprielian R. R., Stevenson S., Rothery S. M., Cullen M. J., Severs N. J., Distinct patterns of dystrophin organization in myocyte sarcolemma and transverse tubules of normal and diseased human myocardium. Circulation 2000 101 22 2586 2594 2-s2.0-0034612267 (Pubitemid 30350636)
50. Kaprielian R. R., Severs N. J., Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart. Heart Failure Reviews 2000 5 3 221 238 2-s2.0-0033680710 10.1023/A:1009805419285
51. Lapidos K. A., Kakkar R., McNally E. M., The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circulation Research 2004 94 8 1023 1031 2-s2.0-2342621479 10.1161/01.RES.0000126574.61061. 25 (Pubitemid 38579696)
52. Johnson E. K., Zhang L., Adams M. E., Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS ONE 2012 7 8 e43515
53. Cox G. F., Kunkel L. M., Dystrophies and heart disease. Current Opinion in Cardiology 1997 12 3 329 343 2-s2.0-0030981051 (Pubitemid 27252541)
54. Finsterer J., Stöllberger C., The heart in human dystrophinopathies. Cardiology 2003 99 1 1 19 2-s2.0-0037276860 10.1159/000068446 (Pubitemid 36206630)
55. Frankel K. A., Rosser R. J., The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Human Pathology 1976 7 4 375 386 2-s2.0-0017122869
56. Miyoshi K., Echocardiographic evaluation of fibrous replacement in the myocardium of patients with Duchenne muscular dystrophy. The British Heart Journal 1991 66 6 452 455 2-s2.0-0026331631
57. McDonald C. M., Abresch R. T., Carter G. T., Fowler W. M. Jr., Johnson E. R., Kilmer D. D., Sigford B. J., Duchenne muscular dystrophy. The American Journal of Physical Medicine and Rehabilitation 1995 74 5, supplement S70 S92 2-s2.0-0028883865
58. Lanza G. A., Russo A. D., Giglio V., de Luca L., Messano L., Santini C., Ricci E., Damiani A., Fumagalli G., de Martino G., Mangiola F., Bellocci F., Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function. The American Heart Journal 2001 141 5 808 812 2-s2.0-0035038322 10.1067/mhj.2001.114804 (Pubitemid 32378491)
59. Groh W. J., Arrhythmias in the muscular dystrophies. Heart Rhythm 2012 9 11 1890 1895 10.1016/j.hrthm.2012.06.038
60. Muntoni F., Cardiomyopathy in muscular dystrophies. Current Opinion in Neurology 2003 16 5 577 583 2-s2.0-0142042349 10.1097/00019052-200310000-00003 (Pubitemid 37290087)
61. Sicinski P., Geng Y., Ryder-Cook A. S., Barnard E. A., Darlison M. G., Barnard P. J., The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989 244 4912 1578 1580 2-s2.0-0024353559 (Pubitemid 19189735)
62. Dowling P., Lohan J., Ohlendieck K., Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of β -dystroglycan. European Journal of Cell Biology 2003 82 5 222 230 2-s2.0-0038823857 10.1078/0171-9335-00315 (Pubitemid 36656568)
63. Marques M. J., Ferretti R., Vomero V. U., Minatel E., Neto H. S., Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle and Nerve 2007 35 3 349 353 2-s2.0-33847684752 10.1002/mus.20697 (Pubitemid 46364090)
64. Carberry S., Brinkmeier H., Zhang Y., Winkler C. K., Ohlendieck K., Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy. International Journal of Molecular Medicine 2013 32 3 544 556 10.3892/ijmm.2013.1429
65. Torres L. F. B., Duchen L. W., The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 1987 110 2 269 299 2-s2.0-0023091942 (Pubitemid 17055813)
66. Carnwath J. W., Shotton D. M., Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. Journal of the Neurological Sciences 1987 80 1 39 54 2-s2.0-0023244894 (Pubitemid 17094623)
67. Coulton G. R., Morgan J. E., Partridge T. A., Sloper J. C., The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathology and Applied Neurobiology 1988 14 1 53 70 2-s2.0-0023910734
68. Stedman H. H., Sweeney H. L., Shrager J. B., Maguire H. C., Panettieri R. A., Petrof B., Narusawa M., Leferovich J. M., Sladky J. T., Kelly A. M., The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991 352 6335 536 539 2-s2.0-0026419948
69. Louboutin J. P., Fichter-Gagnepain V., Thaon E., Fardeau M., Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscular Disorders 1993 3 5-6 463 469 2-s2.0-0027729004 (Pubitemid 24050820)
70. Ameen V., Robson L. G., Experimental models of Duchenne muscular dystrophy: relationship with cardiovascular disease. Open Cardiovascular Medicine Journal 2010 4 2 265 277 2-s2.0-84855494224 10.2174/1874192401004010265
71. Mosqueira M., Zeiger U., Förderer M., Brinkmeier H., Fink R. H., Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers. Medicinial Research Reviews 2013 33 5 1174 1213 10.1002/med.21279
72. Shirokova N., Niggli E., Cardiac phenotype of Duchenne muscular dystrophy: insights from cellular studies. Journal of Molecular and Cellular Cardiology 2013 58 1 217 224 10.1016/j.yjmcc.2012.12.009
73. Partridge T. A., The mdx mouse model as a surrogate for Duchenne muscular dystrophy. Federation of European Biochemical Societies Journal 2013 280 17 4177 4186
74. Bridges L. R., The association of cardiac muscle necrosis and inflammation with the degenerative and persistent myopathy of mdx mice. Journal of the Neurological Sciences 1986 72 2-3 147 157 2-s2.0-0022625394 (Pubitemid 16125194)
75. Lorin C., Gueffier M., Bois P., Faivre J. F., Cognard C., Sebille S., Ultrastructural and functional alterations of EC coupling elements in mdx cardiomyocytes: an analysis from membrane surface to depth. Cell Biochemistry and Biophysics 2013 66 3 723 736 10.1007/s12013-013-9517-8
76. van Erp C., Loch D., Laws N., Trebbin A., Hoey A. J., Timeline of cardiac dystrophy in 3-18-month-old mdx mice. Muscle and Nerve 2010 42 4 504 513 2-s2.0-77957660124 10.1002/mus.21716
77. Verhaart I. E. C., van Duijn R. J. M., den Adel B., Roest A. A. W., Verschuuren J. J. G. M., Aartsma-Rus A., van der Weerd L., Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging. Neuromuscular Disorders 2012 22 5 418 426 2-s2.0-84859635805 10.1016/j.nmd.2011.10.025
78. Quinlan J. G., Hahn H. S., Wong B. L., Lorenz J. N., Wenisch A. S., Levin L. S., Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscular Disorders 2004 14 8-9 491 496 2-s2.0-4344658776 10.1016/j.nmd.2004.04.007 (Pubitemid 39141704)
79. Cheng Y. J., Lang D., Caruthers S. D., Efimov I. R., Chen J., Wickline S. A., Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts. The American Journal of Physiology-Heart and Circulatory Physiology 2012 303 5 H559 H568 10.1152/ajpheart.00321.2012
80. Au C. G., Butler T. L., Sherwood M. C., Egan J. R., North K. N., Winlaw D. S., Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy. International Journal of Experimental Pathology 2011 92 1 57 65 2-s2.0-79251575578 10.1111/j.1365-2613.2010.00750.x
81. Spurney C. F., Knoblach S., Pistilli E. E., Nagaraju K., Martin G. R., Hoffman E. P., Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscular Disorders 2008 18 5 371 381 2-s2.0-43449105011 10.1016/j.nmd.2008.03.008
82. Ieronimakis N., Hays A. L., Janebodin K., Mahoney W. M. Jr., Duffield J. S., Majesky M. W., Reyes M., Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGF β 1 signaling in the mdx mouse model of Duchenne muscular dystrophy. Journal of Molecular and Cellular Cardiology 2013 63 1 122 134 10.1016/j.yjmcc.2013.07.014
83. Nakamura A., Yoshida K., Takeda S., Dohi N., Ikeda S., Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice. FEBS Letters 2002 520 1-3 18 24 2-s2.0-0037024377 10.1016/S0014-5793(02)02739-4 (Pubitemid 34607266)
84. Danialou G., Comtois A. S., Dudley R., Karpati G., Vincent G., Des Rosiers C., Petrof B. J., Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. The FASEB Journal 2001 15 9 1655 1657 2-s2.0-0035403114
85. Hourdé C., Joanne P., Medja F., Mougenot N., Jacquet A., Mouisel E., Pannerec A., Hatem S., Butler-Browne G., Agbulut O., Ferry A., Voluntary physical activity protects from susceptibility to skeletal muscle contraction-induced injury but worsens heart function in mdx mice. The American Journal of Pathology 2013 182 5 1509 1518 10.1016/j.ajpath.2013.01.020
86. Bia B. L., Cassidy P. J., Young M. E., Rafael J. A., Leighton B., Davies K. E., Radda G. K., Clarke K., Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of duchenne muscular dystrophy. Journal of Molecular and Cellular Cardiology 1999 31 10 1857 1862 2-s2.0-0032852539 10.1006/jmcc.1999.1018 (Pubitemid 29458703)
87. Chu V., Otero J. M., Lopez O., Sullivan M. F., Morgan J. P., Amende I., Hampton T. G., Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy. Muscle and Nerve 2002 26 4 513 519 2-s2.0-0036789471 10.1002/mus.10223
88. Zhang W., Hove M. T., Schneider J. E., Stuckey D. J., Sebag-Montefiore L., Bia B. L., Radda G. K., Davies K. E., Neubauer S., Clarke K., Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. Journal of Molecular and Cellular Cardiology 2008 45 6 754 760 2-s2.0-55649122277 10.1016/j.yjmcc.2008.09.125
89. Fayssoil A., Renault G., Guerchet N., Marchiol-Fournigault C., Fougerousse F., Richard I., Cardiac characterization of mdx mice using high-resolution doppler echocardiography. Journal of Ultrasound in Medicine 2013 32 5 757 761 10.7863/ultra.32.5.757
90. Wagner S., Knipp S., Weber C., Hein S., Schinkel S., Walther A., Bekeredjian R., Müller O. J., Friedrich O., The heart in Duchenne muscular dystrophy: early detection of contractile performance alteration. Journal of Cellular and Molecular Medicine 2012 16 12 3028 3036 10.1111/j.1582-4934.2012. 01630.x
91. Sapp J. L., Bobet J., Howlett S. E., Contractile properties of myocardium are altered in dystrophin-deficient mdx mice. Journal of the Neurological Sciences 1996 142 1-2 17 24 2-s2.0-0030272035 10.1016/0022-510X(96)00167-0 (Pubitemid 26340403)
92. Ullrich N. D., Fanchaouy M., Gusev K., Shirokova N., Niggli E., Hypersensitivity of excitation-contraction coupling in dystrophic cardiomyocytes. The American Journal of Physiology-Heart and Circulatory Physiology 2009 297 6 H1992 H2003 2-s2.0-72249122958 10.1152/ajpheart.00602.2009
93. Woolf P. J., Lu S., Cornford-Nairn R., Watson M., Xiao X., Holroyd S. M., Brown L., Hoey A. J., Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. The American Journal of Physiology-Heart and Circulatory Physiology 2006 290 6 H2439 H2445 2-s2.0-33744929843 10.1152/ajpheart.00844.2005 (Pubitemid 43846073)
94. Koenig X., Dysek S., Kimbacher S., Mike A. K., Cervenka R., Lukacs P., Nagl K., Dang X. B., Todt H., Bittner R. E., Hilber K., Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart. PLoS ONE 2011 6 5 2-s2.0-79956359392 10.1371/journal.pone.0020300 e20300
95. 2+ channel contributes to alterations in mitochondrial calcium handling in the mdx ventricular myocyte. The American Journal of Physiology-Heart and Circulatory Physiology 2013 304 6 H767 H775 10.1152/ajpheart.00700.2012
96. Williams I. A., Allen D. G., Intracellular calcium handling in ventricular myocytes from mdx mice. The American Journal of Physiology-Heart and Circulatory Physiology 2007 292 2 H846 H855 2-s2.0-33846958084 10.1152/ajpheart.00688.2006
97. 2+ signalling and reactive oxygen species-generating pathways. Cardiovascular Research 2008 77 4 766 773 2-s2.0-39749095982 10.1093/cvr/cvm089 (Pubitemid 351301866)
98. 2+-binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle. Biochimica et Biophysica Acta-Molecular Basis of Disease 2004 1689 3 252 258 2-s2.0-3242778524 10.1016/j.bbadis.2004.04. 002 (Pubitemid 38981602)
99. Doran P., Dowling P., Donoghue P., Buffini M., Ohlendieck K., Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochimica et Biophysica Acta-Proteins and Proteomics 2006 1764 4 773 785 2-s2.0-33646102225 10.1016/j.bbapap.2006.01.007
100. Williams I. A., Allen D. G., The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. The American Journal of Physiology-Heart and Circulatory Physiology 2007 293 3 H1969 H1977 2-s2.0-34548403018 10.1152/ajpheart.00489.2007 (Pubitemid 47367249)
101. 2+ influx into dystrophic mdx cardiomyocytes. Cell Calcium 2009 46 2 114 121 2-s2.0-68149169018 10.1016/j.ceca.2009.06.002
102. Khairallah M., Khairallah R., Young M. E., Dyck J. R. B., Petrof B. J., des Rosiers C., Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. Journal of Molecular and Cellular Cardiology 2007 43 2 119 129 2-s2.0-34447559663 10.1016/j.yjmcc.2007.05.015 (Pubitemid 47069387)
103. Masubuchi N., Shidoh Y., Kondo S., Takatoh J., Hanaoka K., Subcellular localization of dystrophin isoforms in cardiomyocytes and phenotypic analysis of dystrophin-deficient mice reveal cardiac myopathy is predominantly caused by a deficiency in full-length dystrophin. Experimental Animals 2013 62 3 211 217 10.1538/expanim.62.211
104. Lohan J., Culligan K., Ohlendieck K., Deficiency in cardiac dystrophin affects the abundance of the α -/ β -dystroglycan complex. Journal of Biomedicine and Biotechnology 2005 2005 1 28 36 2-s2.0-22544433443 10.1155/JBB.2005.28 (Pubitemid 41022984)
105. Sharpe K. M., Premsukh M. D., Townsend D., Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin. Journal of Muscle Research and Cell Motility 2013 34 5-6 395 405 10.1007/s10974-013-9362-9
106. Langley S. R., Dwyer J., Drozdov I., Yin X., Mayr M., Proteomics: from single molecules to biological pathways. Cardiovascular Research 2013 97 4 612 622 10.1093/cvr/cvs346
107. Sharma P., Cosme J., Gramolini A. O., Recent advances in cardiovascular proteomics. Journal of Proteomics 2013 81 1 3 14 10.1016/j.jprot.2012.10.026
108. White M. Y., van Eyk J. E., Cardiovascular proteomics: past, present, and future. Molecular Diagnosis and Therapy 2007 11 2 83 95 2-s2.0-34147167728 (Pubitemid 46572569)
109. Edwards A. V. G., White M. Y., Cordwell S. J., The role of proteomics in clinical cardiovascular biomarker discovery. Molecular and Cellular Proteomics 2008 7 10 1824 1837 2-s2.0-55149125606 10.1074/mcp.R800007-MCP200
110. Doehner W., Diagnostic biomarkers in cardiovascular disease: the proteomics approach. European Heart Journal 2012 33 18 2249 2251 10.1093/eurheartj/ehs187
111. McGregor E., Dunn M. J., Proteomics of the heart: unraveling disease. Circulation Research 2006 98 3 309 321 2-s2.0-33646814039 10.1161/01.RES. 0000201280.20709.26
112. Cui Z., Dewey S., Gomes A. V., Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases. The American Journal of Cardiovascular Disease 2011 1 3 274 292
113. Cieniewski-Bernard C., Acosta A., Dubois E., Lamblin N., Beseme O., Chwastyniak M., Amouyel P., Bauters C., Pinet F., Proteomic analysis in cardiovascular diseases. Clinical and Experimental Pharmacology and Physiology 2008 35 4 362 366 2-s2.0-40149102526 10.1111/j.1440-1681.2008.04878.x (Pubitemid 351326763)
114. Sun Z., Hamilton K. L., Reardon K. F., Phosphoproteomics and molecular cardiology: techniques, applications and challenges. Journal of Molecular and Cellular Cardiology 2012 53 3 354 368 10.1016/j.yjmcc.2012.06.001
115. Liddy K. A., White M. Y., Cordwell S. J., Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics. Genome Medicine 2013 5 2, article 20 10.1186/gm424
116. Vivanco F., Heart Proteomics 2013 1005 Methods in Molecular Biology
117. Westbrook J. A., Wheeler J. X., Wait R., Welson S. Y., Dunn M. J., The human heart proteome: two-dimensional maps using narrow-range immobilised pH gradients. Electrophoresis 2006 27 8 1547 1555 2-s2.0-33646235396 10.1002/elps.200500777
118. Raddatz K., Albrecht D., Hochgräfe F., Hecker M., Gotthardt M., A proteome map of murine heart and skeletal muscle. Proteomics 2008 8 9 1885 1897 2-s2.0-43549109223 10.1002/pmic.200700902 (Pubitemid 351678290)
119. Bousette N., Kislinger T., Fong V., Isserlin R., Hewel J. A., Emili A., Gramolini A. O., Large-scale characterization and analysis of the murine cardiac proteome. Journal of Proteome Research 2009 8 4 1887 1901 2-s2.0-65249118832 10.1021/pr800845a
120. Polden J., Mcmanus C. A., dos Remedios C., Dunn M. J., A 2-D gel reference map of the basic human heart proteome. Proteomics 2011 11 17 3582 3586 2-s2.0-80051817548 10.1002/pmic.201000182
121. Cosme J., Emili A., Gramolini A. O., Large-scale characterization of the murine cardiac proteome. Heart Proteomics 2013 1005 1 10 Methods in Molecular Biology 10.1007/978-1-62703-386-2-1
122. Bon E., Steegers R., Steegers E. A. P., Ursem N., Charif H., Burgers P. C., Luider T. M., Dekker L. J. M., Proteomic analyses of the developing chicken cardiovascular system. Journal of Proteome Research 2010 9 1 268 274 2-s2.0-73649095146 10.1021/pr900614w
123. Burniston J. G., Adaptation of the rat cardiac proteome in response to intensity-controlled endurance exercise. Proteomics 2009 9 1 106 115 2-s2.0-59449104541 10.1002/pmic.200800268
124. Burniston J. G., Kenyani J., Wastling J. M., Burant C. F., Qi N. R., Koch L. G., Britton S. L., Proteomic analysis reveals perturbed energy metabolism and elevated oxidative stress in hearts of rats with inborn low aerobic capacity. Proteomics 2011 11 16 3369 3379 2-s2.0-79960759435 10.1002/pmic.201000593
125. Rocha L. A., Petriz B. A., Borges D. H., High molecular mass proteomics analyses of left ventricle from rats subjected to differential swimming training. Biomedcentral Physiology 2012 12 1, article 11 10.1186/1472-6793-12-11
126. Chakravarti B., Oseguera M., Dalal N., Fathy P., Mallik B., Raval A., Chakravarti D. N., Proteomic profiling of aging in the mouse heart: altered expression of mitochondrial proteins. Archives of Biochemistry and Biophysics 2008 474 1 22 31 2-s2.0-43949116272 10.1016/j.abb.2008.02.001
127. Grant J. E., Bradshaw A. D., Schwacke J. H., Baicu C. F., Zile M. R., Schey K. L., Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus. Journal of Proteome Research 2009 8 9 4252 4263 2-s2.0-70350020470 10.1021/pr900297f
128. Dai Q., Escobar G. P., Hakala K. W., Lambert J. M., Weintraub S. T., Lindsey M. L., The left ventricle proteome differentiates middle-aged and old left ventricles in mice. Journal of Proteome Research 2008 7 2 756 765 2-s2.0-39749184236 10.1021/pr700685e (Pubitemid 351294038)
129. Richardson M. R., Lai X., Mason S. B., Miller S. J., Witzmann F. A., Differential protein expression during aging in ventricular myocardium of Fischer 344 × Brown Norway hybrid rats. Experimental Gerontology 2008 43 10 909 918 2-s2.0-53049087690 10.1016/j.exger.2008.07.003
130. Nishtala K., Phong T. Q., Steil L., Proteomic analyses of age related changes in A.BY/SnJ mouse hearts. Proteome Science 2013 11 1, article 29 10.1186/1477-5956-11-29
131. Dabkowski E. R., Baseler W. A., Williamson C. L., Powell M., Razunguzwa T. T., Frisbee J. C., Hollander J. M., Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. The American Journal of Physiology-Heart and Circulatory Physiology 2010 299 2 H529 H540 2-s2.0-77955435653 10.1152/ajpheart.00267.2010
132. Hammer E., Goritzka M., Ameling S., Darm K., Steil L., Klingel K., Trimpert C., Herda L. R., Dörr M., Kroemer H. K., Kandolf R., Staudt A., Felix S. B., Völker U., Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies. Journal of Proteome Research 2011 10 5 2161 2171 2-s2.0-79955848704 10.1021/pr1008042
133. Goudarzi M., Ross M. M., Zhou W., van Meter A., Deng J., Martin L. M., Martin C., Liotta L., Petricoin E., Ad N., Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation. Journal of Proteome Research 2011 10 8 3484 3492 2-s2.0-79961241846 10.1021/pr200108m
134. Zhang P., Wang W., Wang X., Protein analysis of atrial fibrosis via label-free proteomics in chronic atrial fibrillation patients with mitral valve disease. PLoS ONE 2013 8 4 e60210
135. Fessart D., Martin-Negrier M. L., Claverol S., Thiolat M. L., Crevel H., Toussaint C., Bonneu M., Muller B., Savineau J. P., Delom F., Proteomic remodeling of proteasome in right heart failure. Journal of Molecular and Cellular Cardiology 2014 66 41 52 10.1016/j.yjmcc.2013.10.015
136. Dai D. F., Hsieh E. J., Chen T., Menendez L. G., Basisty N. B., Tsai L., Beyer R. P., Crispin D. A., Shulman N. J., Szeto H. H., Tian R., MacCoss M. J., Rabinovitch P. S., Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides. Circulation: Heart Failure 2013 6 5 1067 1076 10.1161/CIRCHEARTFAILURE.113.000406
137. Rabilloud T., Vaezzadeh A. R., Potier N., Lelong C., Leize-Wagner E., Chevallet M., Power and limitations of electrophoretic separations in proteomics strategies. Mass Spectrometry Reviews 2009 28 5 816 843 2-s2.0-69849103563 10.1002/mas.20204
138. Weiss W., Görg A., High-resolution two-dimensional electrophoresis. Proteomics 2009 564 13 32 Methods in Molecular Biology 10.1007/978-1-60761-157- 8-2
139. Friedman D. B., Hoving S., Westermeier R., Chapter 30 isoelectric focusing and two-dimensional gel electrophoresis. Methods in Enzymology 2009 463 515 540 2-s2.0-71849100712 10.1016/S0076-6879(09)63030-5
140. Rabilloud T., Chevallet M., Luche S., Lelong C., Two-dimensional gel electrophoresis in proteomics: past, present and future. Journal of Proteomics 2010 73 11 2064 2077 2-s2.0-77957220211 10.1016/j.jprot.2010.05.016
141. Gulston M. K., Rubtsov D. V., Atherton H. J., Clarke K., Davies K. E., Lilley K. S., Griffin J. L., A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. Journal of Proteome Research 2008 7 5 2069 2077 2-s2.0-52049098971 10.1021/pr800070p
142. Lewis C., Jockusch H., Ohlendieck K., Proteomic profiling of the dystrophin-deficient MDX heart reveals drastically altered levels of key metabolic and contractile proteins. Journal of Biomedicine and Biotechnology 2010 2010 20 2-s2.0-77953491510 10.1155/2010/648501 648501
143. Ohlendieck K., On-membrane digestion technology for muscle proteomics. Journal of Membrane and Separation Technology 2013 2 1 1 12
144. Parker B. L., Palmisano G., Edwards A. V. G., White M. Y., Engholm-Keller K., Lee A., Scott N. E., Kolarich D., Hambly B. D., Packer N. H., Larsen M. R., Cordwell S. J., Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment. Molecular and Cellular Proteomics 2011 10 8 M110.006833 2-s2.0-80051655470 10.1074/mcp.M110.006833
145. Scholten A., Mohammed S., Low T. Y., Zanivan S., van Veen T. A. B., Delanghe B., Heck A. J. R., In-depth quantitative cardiac proteomics combining electron transfer dissociation and the metalloendopeptidase Lys-N with the SILAC mouse. Molecular and Cellular Proteomics 2011 10 10 O111.008474 2-s2.0-84856424567 10.1074/mcp.O111.008474
146. Angel T. E., Aryal U. K., Hengel S. M., Baker E. S., Kelly R. T., Robinson E. W., Smith R. D., Mass spectrometry-based proteomics: existing capabilities and future directions. Chemical Society Reviews 2012 41 10 3912 3928 2-s2.0-84860464109 10.1039/c2cs15331a
147. Rabilloud T., Strub J., Luche S., van Dorsselaer A., Lunardi J., A comparison between Sypro Ruby and ruthenium ii tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels. Proteomics 2001 1 5 699 704 2-s2.0-0035346790 (Pubitemid 33588320)
148. Aude-Garcia C., Collin-Faure V., Luche S., Rabilloud T., Improvements and simplifications in in-gel fluorescent detection of proteins using ruthenium II tris-(bathophenanthroline disulfonate): the poor man's fluorescent detection method. Proteomics 2011 11 2 324 328 2-s2.0-78650788773 10.1002/pmic.201000370
149. Viswanathan S., Ünlü M., Minden J. S., Two-dimensional difference gel electrophoresis. Nature Protocols 2006 1 3 1351 1358 2-s2.0-34248180415 10.1038/nprot.2006.234
150. Timms J. F., Cramer R., Difference gel electrophoresis. Proteomics 2008 8 23-24 4886 4897 2-s2.0-57649153125 10.1002/pmic.200800298
151. Minden J. S., Two-dimensional difference gel electrophoresis. Protein Electrophoresis 2012 869 287 304 Methods in Molecular Biology 10.1007/978-1-61779-821-4-24
152. Carberry S., Zweyer M., Swandulla D., Ohlendieck K., Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research. Biology 2013 2 4 1438 1464 10.3390/biology2041438
153. Doran P., Martin G., Dowling P., Jockusch H., Ohlendieck K., Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 2006 6 16 4610 4621 2-s2.0-33748339008 10.1002/pmic.200600082 (Pubitemid 44336975)
154. Doran P., Wilton S. D., Fletcher S., Ohlendieck K., Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Proteomics 2009 9 3 671 685 2-s2.0-60549096114 10.1002/pmic.200800441
155. Lewis C., Ohlendieck K., Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochemical and Biophysical Research Communications 2010 396 4 1024 1029 2-s2.0-77953292369 10.1016/j.bbrc.2010.05.052
156. Gardan-Salmon D., Dixon J. M., Lonergan S. M., Selsby J. T., Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice. European Journal of Applied Physiology 2011 111 11 2763 2773 2-s2.0-84855685420 10.1007/s00421-011-1906-3
157. Lewis C., Doran P., Ohlendieck K., Proteomic analysis of dystrophic muscle. Myogenesis 2012 798 357 369 Methods in Molecular Biology 10.1007/978-1-61779-343-1-20
158. Carberry S., Zweyer M., Swandulla D., Ohlendieck K., Comparative proteomic analysis of the contractile protein-depleted fraction from normal versus dystrophic skeletal muscle. Analytical Biochemistry 2014 446 1 108 115 10.1016/j.ab.2013.08.004
159. Ünlü M., Morgan M. E., Minden J. S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997 18 11 2071 2077 2-s2.0-0343376097 (Pubitemid 27501267)
160. Alban A., David S. O., Bjorkesten L., Andersson C., Sloge E., Lewis S., Currie I., A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003 3 1 36 44 2-s2.0-0037253267 10.1002/pmic.200390006 (Pubitemid 36151066)
161. Tonge R., Shaw J., Middleton B., Rowlinson R., Rayner S., Young J., Pognan F., Hawkins E., Currie I., Davison M., Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001 1 3 377 396 2-s2.0-0035289178 (Pubitemid 33585112)
162. Marouga R., David S., Hawkins E., The development of the DIGE system: 2D fluorescence difference gel analysis technology. Analytical and Bioanalytical Chemistry 2005 382 3 669 678 2-s2.0-21244495253 10.1007/s00216-005-3126-3 (Pubitemid 40890994)
163. Kang Y., Techanukul T., Mantalaris A., Nagy J. M., Comparison of three commercially available DIGE analysis software packages: minimal user intervention in gel-based proteomics. Journal of Proteome Research 2009 8 2 1077 1084 2-s2.0-61849084174 10.1021/pr800588f
164. Karp N. A., Kreil D. P., Lilley K. S., Determining a significant change in protein expression with DeCyder ™ during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics 2004 4 5 1421 1432 2-s2.0-2442453377 10.1002/pmic.200300681 (Pubitemid 38648032)
165. Karp N. A., Lilley K. S., Maximising sensitivity for detecting changes in protein expression: experimental design using minimal CyDyes. Proteomics 2005 5 12 3105 3115 2-s2.0-23844491490 10.1002/pmic.200500083 (Pubitemid 41176477)
166. Corzett T. H., Fodor I. K., Choi M. W., Walsworth V. L., Chromy B. A., Turteltaub K. W., McCutchen-Maloney S. L., Statistical analysis of the experimental variation in the proteomic characterization of human plasma by two-dimensional difference gel electrophoresis. Journal of Proteome Research 2006 5 10 2611 2619 2-s2.0-33750092954 10.1021/pr060100p (Pubitemid 44595163)
167. Ge Y., Molloy M. P., Chamberlain J. S., Andrews P. C., Proteomic analysis of mdx skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 2003 3 10 1895 1903 2-s2.0-0142182391 10.1002/pmic.200300561 (Pubitemid 37305883)
168. 2+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. European Journal of Biochemistry 2004 271 19 3943 3952 2-s2.0-4944230808 10.1111/j.1432-1033.2004.04332.x (Pubitemid 39331443)
169. Holland A., Carberry S., Ohlendieck K., Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy. Current Protein and Peptide Science 2013 14 8 680 897 10.2174/13892037113146660083
170. Gustafsson A. B., Gottlieb R. A., Heart mitochondria: gates of life and death. Cardiovascular Research 2008 77 2 334 343 2-s2.0-38849156952 10.1093/cvr/cvm005 (Pubitemid 351197632)
171. Taylor S. W., Fahy E., Zhang B., Glenn G. M., Warnock D. E., Wiley S., Murphy A. N., Gaucher S. P., Capaldi R. A., Gibson B. W., Ghosh S. S., Characterization of the human heart mitochondrial proteome. Nature Biotechnology 2003 21 3 281 286 2-s2.0-0037336905 10.1038/nbt793 (Pubitemid 36314812)
172. Gaucher S. P., Taylor S. W., Fahy E., Zhang B., Warnock D. E., Ghosh S. S., Gibson B. W., Expanded coverage of the human heart mitochondrial proteome using multidimensional liquid chromatography coupled with tandem mass spectrometry. Journal of Proteome Research 2004 3 3 495 505 2-s2.0-4444376922 10.1021/pr034102a (Pubitemid 39207354)
173. Forner F., Foster L. J., Campanaro S., Valle G., Mann M., Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver. Molecular and Cellular Proteomics 2006 5 4 608 619 2-s2.0-33645704767 10.1074/mcp.M500298-MCP200
174. Culligan K. G., Mackey A. J., Finn D. M., Maguire P. B., Ohlendieck K., Role of dystrophin isoforms and associated proteins in muscular dystrophy (review). International Journal of Molecular Medicine 1998 2 6 639 648 2-s2.0-0032246520
175. Domogatskaya A., Rodin S., Tryggvason K., Functional diversity of laminins. Annual Review of Cell and Developmental Biology 2012 28 1 523 553 10.1146/annurev-cellbio-101011-155750
176. Ho M. S., Böse K., Mokkapati S., Nischt R., Smyth N., Nidogens-extracellular matrix linker molecules. Microscopy Research and Technique 2008 71 5 387 395 2-s2.0-42949163951 10.1002/jemt.20567 (Pubitemid 351620861)
177. 2+ handling in the heart. Cardiovascular Research 2005 65 4 793 802 2-s2.0-13844255153 10.1016/j.cardiores.2004.11.010 (Pubitemid 40249725)
178. Wasala N. B., Bostick B., Yue Y., Duan D., Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy. Human Molecular Genetics 2013 22 13 2634 2641 10.1093/hmg/ddt112
179. Yue Y., Li Z., Harper S. Q., Davisson R. L., Chamberlain J. S., Duan D., Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 2003 108 13 1626 1632 2-s2.0-0141841602 10.1161/01.CIR.0000089371.11664.27 (Pubitemid 37187791)
180. Wehling-Henricks M., Jordan M. C., Roos K. P., Deng B., Tidball J. G., Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Human Molecular Genetics 2005 14 14 1921 1933 2-s2.0-26444450721 10.1093/hmg/ddi197 (Pubitemid 41418029)
181. Shin J. H., Nitahara-Kasahara Y., Hayashita-Kinoh H., Ohshima-Hosoyama S., Kinoshita K., Chiyo T., Okada H., Okada T., Takeda S., Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction. Gene Therapy 2011 18 9 910 919 2-s2.0-80052594894 10.1038/gt.2011.36
182. Bostick B., Shin J. H., Yue Y., Wasala N. B., Lai Y., Duan D., AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. Journal of Molecular and Cellular Cardiology 2012 53 2 217 222 10.1016/j.yjmcc.2012.05.002
183. Wu B., Moulton H. M., Iversen P. L., Jiang J., Li J., Li J., Spurney C. F., Sali A., Guerron A. D., Nagaraju K., Doran T., Lu P., Xiao X., Qi L. L., Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proceedings of the National Academy of Sciences of the United States of America 2008 105 39 14814 14819 2-s2.0-54449095504 10.1073/pnas.0805676105
184. Buyse G. M., van der Mieren G., Erb M., D'hooge J., Herijgers P., Verbeken E., Jara A., van den Bergh A., Mertens L., Courdier-Fruh I., Barzaghi P., Meier T., Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. European Heart Journal 2009 30 1 116 124 2-s2.0-58149173164 10.1093/eurheartj/ehn406
185. Spurney C. F., Sali A., Guerron A. D., Iantorno M., Yu Q., Gordish-Dressman H., Rayavarapu S., van der Meulen J., Hoffman E. P., Nagaraju K., Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice. Journal of Cardiovascular Pharmacology and Therapeutics 2011 16 1 87 95 2-s2.0-79951479823 10.1177/1074248410381757
186. Hori Y. S., Kuno A., Hosoda R., Tanno M., Miura T., Shimamoto K., Horio Y., Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Journal of Pharmacology and Experimental Therapeutics 2011 338 3 784 794 2-s2.0-80052144579 10.1124/jpet.111.183210
187. Delfín D. A., Xu Y., Schill K. E., Mays T. A., Canan B. D., Zang K. E., Barnum J. A., Janssen P. M., Rafael-Fortney J. A., Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model. Molecular Therapy 2012 20 7 1378 1383 2-s2.0-84860560061 10.1038/mt.2012.81
188. Blain A., Greally E., Laval S., Blamire A., Straub V., MacGowan G. A., Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy. PLoS ONE 2013 8 2 e57260
189. Vianello S., Yu H., Voisin V., Haddad H., He X., Foutz A. S., Sebrié C., Gillet B., Roulot M., Fougerousse F., Perronnet C., Vaillend C., Matecki S., Escolar D., Bossi L., Israël M., de la Porte S., Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy. Federation of American Societies for Experimental Biology Journal 2013 27 6 2256 2269 10.1096/fj.12-215723
190. Ather S., Wang W., Wang Q., Li N., Anderson M. E., Wehrens X. H., Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy. Heart Rhythm 2013 10 4 592 599 10.1016/j.hrthm.2012.12.016
191. Berry S. E., Andruszkiewicz P., Chun J. L., Hong J., Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells. Stem Cells Translational Medicine 2013 2 11 848 861 10.5966/sctm.2012-0174
192. Sciorati C., Staszewsky L., Zambelli V., Russo I., Salio M., Novelli D., Di Grigoli G., Moresco R. M., Clementi E., Latini R., Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure. Pharmacological Research 2013 73 1 35 43 10.1016/j.phrs.2013.04.009
193. Ohlendieck K., Proteomic identification of biomarkers of skeletal muscle disorders. Biomarkers in Medicine 2013 7 1 169 186 10.2217/bmm.12.96